OBI-3424, a novel AKR1C3-activated prodrug, exhibits potent efficacy against preclinical models of T-ALL

K Evans, JX Duan, T Pritchard, CD Jones… - Clinical Cancer …, 2019 - AACR
Purpose: OBI-3424 is a highly selective prodrug that is converted by aldo-keto reductase
family 1 member C3 (AKR1C3) to a potent DNA-alkylating agent. OBI-3424 has entered …
被引用次数：43 相关文章

OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALL

K Evans, JX Duan, T Pritchard… - … : an official journal …, 2019 - pubmed.ncbi.nlm.nih.gov
Purpose OBI-3424 is a highly selective prodrug that is converted by aldo-keto reductase
family 1 member C3 (AKR1C3) to a potent DNA-alkylating agent. OBI-3424 has entered …

OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALL

K Evans, JX Duan, T Pritchard, CD Jones… - Clinical Cancer …, 2019 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Purpose:</jats: title>< jats: p> OBI-
3424 is a highly selective prodrug that is converted by aldo-keto reductase family 1 member …
[PDF] ascentawits.com

[PDF][PDF] OBI-3424, a novel AKR1C3-activated prodrug, exhibits potent efficacy against preclinical models of T-ALL

K Evans, JX Duan, T Pritchard, CD Jones… - Clin Cancer …, 2019 - ascentawits.com
Background: OBI-3424 is a highly selective prodrug that is converted by aldo-keto reductase
family 1 member C3 (AKR1C3) to a potent DNA alkylating agent. OBI-3424 has entered …

OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALL.

K Evans, J Duan, T Pritchard, CD Jones… - … Cancer Research: an …, 2019 - europepmc.org
Purpose OBI-3424 is a highly selective prodrug that is converted by aldo-keto reductase
family 1 member C3 (AKR1C3) to a potent DNA-alkylating agent. OBI-3424 has entered …

OBI-3424, a novel AKR1c3-activated prodrug, exhibits potent efficacy against preclinical models of T-ALL

K Evans, JX Duan, T Pritchard, CD Jones… - 2019 - digital.library.adelaide.edu.au
PURPOSE: OBI-3424 is a highly selective prodrug that is converted by aldo-keto reductase
family 1 member C3 (AKR1C3) to a potent DNA-alkylating agent. OBI-3424 has entered …
[HTML] nih.gov

[HTML][HTML] OBI-3424, a novel AKR1C3-activated prodrug, exhibits potent efficacy against preclinical models of T-ALL

K Evans, JX Duan, T Pritchard, CD Jones… - … cancer research: an …, 2019 - ncbi.nlm.nih.gov
Background: OBI-3424 is a highly selective prodrug that is converted by aldo-keto reductase
family 1 member C3 (AKR1C3) to a potent DNA alkylating agent. OBI-3424 has entered …

OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALL.

K Evans, J Duan, T Pritchard, CD Jones… - … Cancer Research: an …, 2019 - europepmc.org
Purpose OBI-3424 is a highly selective prodrug that is converted by aldo-keto reductase
family 1 member C3 (AKR1C3) to a potent DNA-alkylating agent. OBI-3424 has entered …